SCHEMBL2482540

SCHEMBL2482540

CN1C2CCC1CC(OC(=O)C(Nc1ccccc1)c1ccccc1)C2

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.67
CYP2D6 P10635 3/20 0.67
CYP2C9 P11712 1/20 0.67
HSD17B10 Q99714 1/20 0.67
CHRM2 P08172 7/20 0.65
CHRM5 P08912 7/20 0.65
CHRM1 P11229 7/20 0.65
CHRM3 P20309 7/20 0.65
CHRM4 P08173 6/20 0.65
BLM P54132 2/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
TDP1 Q9NUW8 1/20 0.65
HTR2C P28335 3/20 0.62
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
ADRA2C P18825 2/20 0.62
ADRA1A P35348 2/20 0.62
HRH1 P35367 2/20 0.62
ADRA1D P25100 2/20 0.62
KDM4E B2RXH2 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19894848 0.89 LMNA (0.57) LMNACYP2D6CYP2C9HSD17B10CHRM2
SCHEMBL2512019 0.84 CHRM3 (0.54) LMNACYP2D6CYP2C9HSD17B10CHRM2
SCHEMBL2482977 0.84 CHRM3 (0.54) LMNACYP2D6CYP2C9HSD17B10CHRM2
SCHEMBL13240786 0.82 CHRM1 (0.65) LMNACYP2D6CYP2C9HSD17B10CHRM2
SCHEMBL2484712 0.81 CYP2D6 (0.59) LMNACYP2D6CYP2C9HSD17B10CHRM2
SCHEMBL2985056 0.81 CYP2D6 (0.59) LMNACYP2D6CYP2C9HSD17B10CHRM2
SCHEMBL2995294 0.81 CYP2D6 (0.59) LMNACYP2D6CYP2C9HSD17B10CHRM2
SCHEMBL8872524 0.81 LMNA (0.77) LMNACYP2D6CYP2C9HSD17B10CHRM2
SCHEMBL250617 0.81 LMNA (0.77) LMNACYP2D6CYP2C9HSD17B10CHRM2
SCHEMBL23494999 0.80 CYP2D6 (0.76) LMNACYP2D6CYP2C9HSD17B10CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376489-B1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMA SPA (IT) 2015-04-22 EP claimed
US-8455646-B2 Alkaloid aminoester derivatives and medicinal composition thereof CHIESI FARMACEUTICI S.P.A. (IT) 2013-06-04 US claimed
US-20100173880-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2010-07-08 US claimed
EP-2376489-B1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMA SPA (IT) 2015-04-22 EP disclosed
US-8835682-B2 Alkaloid aminoester derivatives and medicinal composition thereof CHIESI FARMACEUTICI S.P.A. (IT) 2014-09-16 US disclosed
US-8835682-B2 Alkaloid aminoester derivatives and medicinal composition thereof CHIESI FARMACEUTICI S.P.A. (IT) 2014-09-16 US disclosed
US-20130196978-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2013-08-01 US disclosed
US-20130196978-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2013-08-01 US disclosed
US-8455646-B2 Alkaloid aminoester derivatives and medicinal composition thereof CHIESI FARMACEUTICI S.P.A. (IT) 2013-06-04 US disclosed
US-8455646-B2 Alkaloid aminoester derivatives and medicinal composition thereof CHIESI FARMACEUTICI S.P.A. (IT) 2013-06-04 US disclosed
EP-2376489-A1 Alkaloid aminoester derivatives and medicinal composition thereof Chiesi Farmaceutici S.p.A. (IT) 2011-10-19 EP disclosed
EP-2206712-A1 \"Alkaloid aminoester derivatives and medicinal composition thereof\ CHIESI FARMACEUTICI S.p.A. (IT) 2010-07-14 EP disclosed
US-20100173880-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2010-07-08 US disclosed
US-20100173880-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2010-07-08 US disclosed
WO-2010072338-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2010-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130196978-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHRM3, CHRM1, CHRNG LMNA 3557/4885CYP2D6 2637/4885CYP2C9 1781/4885
US-20100173880-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHRM3, CHRM1, CHRNG LMNA 3557/4885CYP2D6 2637/4885CYP2C9 1781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.